Since 1967, Fermilab has worked to answer these and other fundamental questions and enhance our understanding of everything we see around us. As the United States' premier particle physics laboratory, we work on the world's most advanced particle accelerators and dig down to the smallest building blocks of matter.
So, survival rate and life expectancy for stage 4 prostate cancer cannot be favorable. âº The five-year relative survival rate for prostate cancer that has spread to distant organs is 28%. This means about 28% of the patients with stage 4 prostate cancer will live for five years.
There is only about 30 percent (1 of every 3 patients with stage 4) who have life expectancy for live at least five years after the diagnosis was made. Again, this estimation is relative which only associated with the cancer of prostate (doesnât include other health conditions that may lead to the death in this group).